News & Perspective

Oct 18, 2001

Oct 18, 2001

S pneumoniae resistance to macrolides is now common, CDC says

(CIDRAP News) – Macrolide antibiotics, the mainstay of treatment for community-acquired pneumonia, are encountering increasing resistance from Streptococcus pneumoniae, the most common cause of the disease, according to a report in the Oct 17 issue of the Journal of the American Medical Association.